Abbott Laboratories (NYSE:ABT) currently has a daily average trading volume of 5.56M but it saw 3655620 shares traded in last market. With a market cap of 203.59B USD, the company’s current market price of $117.01 came rising about 0.77 while comparing to the previous closing price of $116.12. In past 52 weeks, the stock remained buoying in the range of price level as high as $121.64 and as low as $91.64. In the recent trading on the day, stock has struck highest price mark of $115.93 while lowest mark touched by it was $117.15.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which initiated the stock as “Outperform” in its note to investors issued on October 08, 2024, recommending a price target of $130 for it.
Over the week, ABT’s stock price is moving -0.69% down while it is 3.24% when we observe its performance for the past one month. Year-to-date it is 6.31% up and over the past year, the stock is showing an upside performance of 22.17%.
Currently, Abbott Laboratories’s total number of outstanding shares is 1.73B. Company’s return on investment (ROI) stands at 10.96% and return on equity (ROE) at 14.47%. It has a price to earnings ratio (P/E ratio) of 35.55 while having a 22.68 of forward P/E ratio. Stock’s beta reads 0.72. Stock has a price to book (P/B) ratio of 5.18 while price to sale or P/S ratio amounts to 4.94. Its return on asset (ROA) is 7.56% on average.
